Skip to main content
gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
EBV-specific T cells recognize LMP1-derived peptides presented on HLA via their native TCRs and directly kill target cells through perforin/granzyme release (and Fas–FasL apoptosis).
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
Latent EBV antigen; peptide presented on HLA class I (CD8+) and/or class II (CD4+)
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06391814
disease_id_num_tar_ref
2596
drug_id_num_tar_ref
6932